Product Code: ETC8842243 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Philippines glomerular disease therapeutics market is expanding due to the increasing prevalence of kidney-related disorders. Treatment options include corticosteroids, immunosuppressants, and targeted therapies aimed at reducing inflammation and preserving kidney function. Growing healthcare awareness and improvements in nephrology care are contributing to market growth.
The rising prevalence of kidney-related disorders, including glomerular diseases, is driving demand for advanced therapeutics in the Philippines. Increased healthcare expenditure, government initiatives for kidney disease awareness, and advancements in biologics and targeted therapies are improving treatment options. Additionally, the expansion of dialysis centers and nephrology clinics is supporting market growth.
The treatment of glomerular diseases in the Philippines is challenged by the high cost of immunosuppressants and other therapies. Limited access to nephrology specialists, particularly in remote areas, affects early diagnosis and management. The absence of strong government support for rare kidney diseases further hampers patient outcomes. Additionally, the lack of local clinical trials results in fewer treatment innovations reaching the market.
The rising prevalence of kidney-related diseases in the Philippines is fueling demand for innovative glomerular disease therapeutics. Investments in biologics, immunosuppressants, and targeted therapies are increasing as healthcare providers focus on improving treatment outcomes. Pharmaceutical companies developing novel therapeutics for nephrological conditions can benefit from the growing healthcare expenditure and government support for renal disease management.
The Philippine government is strengthening healthcare policies to support the treatment of glomerular diseases through improved access to specialized medicines. The Department of Health (DOH) is working on expanding the national insurance coverage for kidney-related illnesses, making treatments more affordable. Additionally, investments in nephrology research and hospital infrastructure are enhancing diagnostic capabilities and patient care. Regulatory authorities, such as the Food and Drug Administration (FDA), are ensuring that innovative glomerular disease therapies undergo rigorous approval processes while maintaining accessibility for Filipino patients.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Glomerular Disease Therapeutics Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Glomerular Disease Therapeutics Market - Industry Life Cycle |
3.4 Philippines Glomerular Disease Therapeutics Market - Porter's Five Forces |
3.5 Philippines Glomerular Disease Therapeutics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Philippines Glomerular Disease Therapeutics Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Philippines Glomerular Disease Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Philippines Glomerular Disease Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Philippines Glomerular Disease Therapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Glomerular Disease Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Glomerular Disease Therapeutics Market Trends |
6 Philippines Glomerular Disease Therapeutics Market, By Types |
6.1 Philippines Glomerular Disease Therapeutics Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, By Glomerulonephritis, 2021- 2031F |
6.1.4 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, By Nephropathy, 2021- 2031F |
6.1.5 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, By Goodpasture Syndrome, 2021- 2031F |
6.1.6 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Philippines Glomerular Disease Therapeutics Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.2.3 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, By Aristocort, 2021- 2031F |
6.2.4 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, By Bubbli-Pred, 2021- 2031F |
6.2.5 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, By Celestone, 2021- 2031F |
6.2.6 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, By ACE Inhibitors, 2021- 2031F |
6.2.7 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, By Benazepril, 2021- 2031F |
6.3 Philippines Glomerular Disease Therapeutics Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Philippines Glomerular Disease Therapeutics Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Philippines Glomerular Disease Therapeutics Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Philippines Glomerular Disease Therapeutics Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Philippines Glomerular Disease Therapeutics Market Import-Export Trade Statistics |
7.1 Philippines Glomerular Disease Therapeutics Market Export to Major Countries |
7.2 Philippines Glomerular Disease Therapeutics Market Imports from Major Countries |
8 Philippines Glomerular Disease Therapeutics Market Key Performance Indicators |
9 Philippines Glomerular Disease Therapeutics Market - Opportunity Assessment |
9.1 Philippines Glomerular Disease Therapeutics Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Philippines Glomerular Disease Therapeutics Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Philippines Glomerular Disease Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Philippines Glomerular Disease Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Philippines Glomerular Disease Therapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Glomerular Disease Therapeutics Market - Competitive Landscape |
10.1 Philippines Glomerular Disease Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Philippines Glomerular Disease Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |